Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum

Proteomics - Clinical Applications

Volumn 3, Issue 1, 2009, Pages 106-115

  Scherer, H Ulrich ^a,b   Wang, Jun ^a   Toes, René E M ^a   van der Woude, Diane ^a   Koeleman, Carolien A M ^a   de Boer, Arjen R ^a   Huizinga, Tom W J ^a   Deelder, André M ^a   Wuhrer, Manfred ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antibody; Antigen; Immunoglobulin; Mass spectrometry

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1;

ANALYTIC METHOD; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HUMAN; IMMUNOASSAY; INFLAMMATION; JOINT DESTRUCTION; PRIORITY JOURNAL; PURIFICATION; RHEUMATOID ARTHRITIS;

EID: 61349137819     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800098     Document Type: Article

References (26)

1. Holland, M., Yagi, H., Takahashi, N., Kato, K. et al., Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim. Biophys. Acta 2006, 1760, 669-677.
2. Youings, A., Chang, S. C., Dwek, R. A., Scragg, I. G., Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem. J. 1996, 314, 621-630.
3. Mimura, Y., Ashton, P. R., Takahashi, N., Harvey, D. J., Jefferis, R., Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. J. Immunol. Methods 2007, 326, 116-126.
4. Lim, A., Reed-Bogan, A., Harmon, B. J., Glycosylation profiling of a therapeutic recombinant monoclonal antibody with two N-linked glycosylation sites using liquid chromatography coupled to a hybrid quadrupole time-of-flight mass spectrometer. Anal. Biochem. 2008, 375, 163-172.
5. Qian, J., Liu, T., Yang, L., Daus, A. et al., Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal. Biochem. 2007, 364, 8-18.
6. Huang, L., Biolsi, S., Bales, K. R., Kuchibhotla, U., Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. Anal. Biochem. 2006, 349, 197-207.
7. Parekh, R., Roitt, I., Isenberg, D., Dwek, R., Rademacher, T., Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 1988, 167, 1731-1736.
8. Yamada, E., Tsukamoto, Y., Sasaki, R., Yagyu, K., Takahashi, N., Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj. J. 1997, 14, 401-405.
9. Shikata, K., Yasuda, T., Takeuchi, F., Konishi, T. et al., Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconj. J. 1998, 15, 683-689.
10. Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., Dwek, R. A., The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 2007, 25, 21-50.
11. Rook, G. A. W., Steele, J., Brealey, R., Whyte, A. et al., Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimmun. 1991, 4, 779-794.
12. Wuhrer, M., Stam, J. C., van de Geijn, F. E., Koeleman, C. A. M. et al., Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 2007, 7, 4070-4081.
13. Rademacher, T. W., Williams, P., Dwek, R. A., Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. U S A 1994, 91, 6123-6127.
14. Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y. et al., Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 2002, 277, 26733-26740.
15. Okazaki, A., Shoji-Hosaka, E., Nakamura, K., Wakitani, M. et al., Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. J. Mol. Biol. 2004, 336, 1239-1249.
16. Kaneko, Y., Nimmerjahn, F., Ravetch, J. V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006, 313, 670-673.
17. Mimura, Y., Sondermann, P., Ghirlando, R., Lund, J. et al., Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J. Biol. Chem. 2001, 276, 45539-45547.
18. Shoji-Hosaka, E., Kobayashi, Y., Wakitani, M., Uchida, K. et al., Enhanced Fc-dependent cellular cytotoxicity of Fc fusion proteins derived from TNF receptor II and LFA-3 by fucose removal from Asn-linked oligosaccharides. J. Biochem. (Tokyo) 2006, 140, 777-783.
19. Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E. et al., The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 2003, 278, 3466-3473.
20. Kanda, Y., Yamada, T., Mori, K., Okazaki, A. et al., Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: The high-mannose, hybrid, and complex types. Glycobiology 2007, 17, 104-118.
21. Mehta, A. S., Long, R. E., Comunale, M. A., Wang, M. et al., Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J. Virol. 2008, 82, 1259-1270.
22. Klareskog, L., Ronnelid, J., Lundberg, K., Padyukov, L., Alfredsson, L., Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 2008, 26, 651-675.
23. Holers, V. M., Antibodies to citrullinated proteins: Pathogenic and diagnostic significance. Curr. Rheumatol. Rep. 2007, 9, 396-400.
24. Raptopoulou, A., Sidiropoulos, P., Katsouraki, M., Boumpas, D. T., Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: Evolving concepts. Crit. Rev. Clin. Lab. Sci. 2007, 44, 339-363.
25. Verpoort, K. N., Jol-van der Zijde, C. M., Papendrecht-van der Voort, E. A., Ioan-Facsinay, A. et al., Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum. 2006, 54, 3799-3808.
26. van Gaalen, F., Ioan-Facsinay, A., Huizinga, T. W., Toes, R. E., The devil in the details: The emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J. Immunol. 2005, 175, 5575-5580.